Armed oncolytic adenovirus can overcome critical obstacles in adoptive T-cell therapy of solid tumors

被引：0
|
作者：
Hemminki, Akseli [1 ,2 ,3 ]
Siurala, Mikko [1 ,2 ,3 ]
Tahtinen, Siri
Jokimaki, Riikka
Bramante, Simona
Parviainen, Suvi
机构：
[1] Univ Helsinki, Haartman Inst, Dept Pathol, Canc Gene Therapy Grp, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Transplantat Lab, FIN-00014 Helsinki, Finland
[3] TILT Biotherapeut Ltd, Helsinki, Finland
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
INV085
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [11] Oncolytic adenovirus improves anti-tumor efficacy of adoptive T-cell therapy by breaking tumor tolerance
    Tahtinen, S.
    Gronberg-Vaha-Koskela, S.
    Lumen, D.
    Merisalo-Soikkeli, M.
    Siurala, M.
    Airaksinen, A. J.
    Vaha-Koskela, M.
    Hemminki, A.
    HUMAN GENE THERAPY, 2015, 26 (10) : A33 - A33
  • [12] Improving the therapeutic effect of adoptive T-cell therapy by oncolytic adenovirus encoding CD40-ligand
    Parviainen, S.
    Zafar, S.
    Bramante, S.
    Hemminki, O.
    Siurala, M.
    Havunen, R.
    Diaconu, I.
    Hemminki, A.
    HUMAN GENE THERAPY, 2015, 26 (10) : A96 - A97
  • [13] Targeting the tumor stroma with a bispecific T-cell engager-armed oncolytic adenovirus
    de Sostoa Pomes, J.
    Fajardo, C. A.
    Moreno, R.
    Ramon, M. D.
    Farrera Sal, M.
    Alemany, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 34 - 34
  • [14] Optimizing Adoptive Cell Therapy for Solid Tumors via Epigenetic Regulation of T-cell Destiny
    Guo, Xuemeng
    Li, Xiang
    Wang, Sijie
    Shi, Yingying
    Huang, Jiaxin
    Liu, Xu
    Lu, Yichao
    Zhang, Junlei
    Luo, Lihua
    You, Jian
    ADVANCED HEALTHCARE MATERIALS, 2024,
  • [15] Tumor Antigen Heterogeneity: The "Elephant in the Room" of Adoptive T-cell Therapy for Solid Tumors
    Albelda, Steven M.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (01) : 2 - 2
  • [16] Adoptive T-cell therapy for the treatment of solid tumours
    Knutson, KL
    Almand, B
    Mankoff, DA
    Schiffman, K
    Disis, ML
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 55 - 66
  • [17] SUSTAINABLE REGRESSION OF DISSEMINATED SOLID TUMORS MEDIATED BY IN SITU COMBINATIONAL TREATMENT WITH ADOPTIVE T CELL THERAPY AND ONCOLYTIC ADENOVIRUS DELTA-24-RGDOX
    Jiang, Hong
    Shin, Dong Ho
    Sohoni, Sagar
    Nguyen, Teresa
    Yi, Yanhua
    Fan, Xuejun
    Gumin, Joy
    Singh, Sanjay
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A640 - A640
  • [18] Adoptive T-Cell Therapy for Cheek for Solid Malignancies
    Jafferji, Mohammad S.
    Yang, James C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (03) : 465 - +
  • [19] Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumors
    Hartley, Jordan
    Abken, Hinrich
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (06)
  • [20] Oncolytic Adenovirus Breaks Tumor Tolerance To Adoptive T-Cell Therapy By Recruiting Immune Cells To and Promoting Their Activity in the Tumor
    Tahtinen, Siri
    Gronberg-Vaha-Koskela, Susanna
    Lumen, Dave
    Merisalo-Soikkeli, Maiju
    Siurala, Mikko
    Airaksinen, Anu J.
    Vaha-Koskela, Markus
    Hemminki, Akseli
    MOLECULAR THERAPY, 2015, 23 : S288 - S289
12345